EUVIMEDEUVIMED entdecken
Crossref

Light-Activated CD36-Targeted Cuproptosis Triggers Metabolic-Immune Synergy for Precision Breast Cancer Therapy

Shiwen Wang, Ying Shen, Binbin Hu, Qiping Wu, Nanzhou Wang, Zichao Wang, Zifeng Zhang, Yujie Li iD, Jianhui Jiang iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c11318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Shiwen Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Hunan University, Changsha 410082, China. Hauptthemen laut MEDLINE: Copper, Breast Neoplasms, CD36 Antigens, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperBreast NeoplasmsCD36 AntigensAntineoplastic AgentsAnimalsFemaleHumansMiceDisulfiramCell Line, TumorInfrared RaysDitiocarb

Stichwörter der Autor:innen

CD36cancer immunotherapycuproptosislipid metabolism reprogramphase-transitional material

Substanzen

CopperCD36 AntigensDisulfiramAntineoplastic AgentsDitiocarb

Autor:innen und Institutionen

  • School of Biomedical Sciences, Hunan University, Changsha 410082, China.
  • Center for Bioanalytical Chemistry, Hefei National Laboratory of Physical Science at Microscale, University of Science and Technology of China, Hefei 230000, China.
  • Departments of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Henan Provincial Key Laboratory of Nanocomposites and Applications, Institute of Nanostructured Functional Materials, Huanghe Science and Technology College, Zhengzhou, Henan 450006, China.
  • Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao 266071, China.

ORCID-Profile: Yujie Li, Jianhui Jiang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, S., Shen, Y., Hu, B., Wu, Q., Wang, N., Wang, Z., Zhang, Z., Li, Y., & Jiang, J. (2025). Light-Activated CD36-Targeted Cuproptosis Triggers Metabolic-Immune Synergy for Precision Breast Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c11318

Vancouver

Wang S, Shen Y, Hu B, Wu Q, Wang N, Wang Z, et al. Light-Activated CD36-Targeted Cuproptosis Triggers Metabolic-Immune Synergy for Precision Breast Cancer Therapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c11318

BibTeX
@article{Wang2025,
  author = {Wang, Shiwen and Shen, Ying and Hu, Binbin and Wu, Qiping and Wang, Nanzhou and Wang, Zichao and Zhang, Zifeng and Li, Yujie and Jiang, Jianhui},
  title = {Light-Activated CD36-Targeted Cuproptosis Triggers Metabolic-Immune Synergy for Precision Breast Cancer Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c11318}
}
Kostenlos starten →